• JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
  • JoomlaWorks Simple Image Rotator
 
  Bookmark and Share
 
 
Doctoral Thesis
DOI
https://doi.org/10.11606/T.42.2007.tde-17102007-183226
Document
Author
Full name
Alexandre Ferreira Marques
Institute/School/College
Knowledge Area
Date of Defense
Published
São Paulo, 2007
Supervisor
Committee
Taborda, Carlos Pelleschi (President)
Almeida, Sandro Rogerio de
Benard, Gil
Puccia, Rosana
Travassos, Luiz Rodolpho Raja Gabaglia
Title in Portuguese
Utilização de peptídeo sintético (P10) associado ao tratamento com drogas antifúngicas no controle da paracoccidioidomicose experimental
Keywords in Portuguese
Adjuvantes imunológicos
Anergia
Antifúngicos
P. brasiliensis
Paracoccidioidomicose
Peptídeo sintético
Abstract in Portuguese
A paracoccidioidomicose (PCM), doença sistêmica de caráter granulomatoso, causada pelo fungo termodimórfico Paracoccidioides brasiliensis. A PCM é endêmica na América Latina e atinge principalmente indivíduos do sexo masculino com atividades econômica ligada a agricultura. Os pacientes com PCM exigem tratamento a base de sulfametoxazol/trimetoprim, anfotericina B, e derivados azólicos por longos períodos. A gp43, possui 416 aminoácidos, onde um trecho específico de 15 aminoácidos (QTLIAIHTLAIRYAN) designado como (P10), é reconhecido pelos linfócitos T de camundongos e humanos. No presente estudo avaliamos o efeito aditivo da imunização do P10 com às drogas antifúngicas utilizadas no tratamento da PCM. Nossos resultados indicam um efeito aditivo entre a imunização com P10 e o tratamento medicamentoso em camundongos Balb/c infectados. Associado a redução significativa da carga fúngica no pulmão, baço e fígado desses animais, detectamos aumento dos níveis de IL-12 e IFN-? e diminuição de IL-4 e IL-10.
Title in English
Use of synthetic peptide (P10) associate with antifungal drugs to the treatment in the control of experimental paracoccidioidomyicosis.
Keywords in English
adjuvants
anergy
P. brasiliensis
P10
paracoccidioidomycosis
sulfamethoxazole-trimethoprim
treatment.
Abstract in English
Paracoccidioidomycosis (PCM) is a systemic granulomatous disease caused by Paracoccidioides brasiliensis, a thermal dimorphic fungus. PCM is endemic in Latin America affecting mainly rural workers. The patients with PCM demand treatment the base of sulfametoxazole/trimethoprim, amphotericin B and derivatives azolic. The gp43 has 416-mer and mice and human T lymphocytes are stimulated by a 15-mer peptide designated as P10 (QTLIAIHTLAIRYAN). In the present work we evaluated the additive effect of P10 immunization and antifungal drugs utilizing in PCM treatment. Ours results showed an additive protective effect between immunization with P10 and drugs treatment with infected Balb/c mice. Associated to the reduction of fungal burden in the lung, spleen and liver we observed increase of levels of IL-12 and IFN-? and reduction of IL-4 and IL-10.
 
WARNING - Viewing this document is conditioned on your acceptance of the following terms of use:
This document is only for private use for research and teaching activities. Reproduction for commercial use is forbidden. This rights cover the whole data about this document as well as its contents. Any uses or copies of this document in whole or in part must include the author's name.
TDE200706.pdf (1.19 Mbytes)
Publishing Date
2007-10-17
 
WARNING: The material described below relates to works resulting from this thesis or dissertation. The contents of these works are the author's responsibility.
  • AMARAL, A. C., et al. Poly(lactic-co-glycolic acid) (PLGA) nanoparticles strongly improve the immunological protection of peptide P10 against murine paracoccidioidomycosis [doi:10.1111/j.1476-5381.2009.00617.x]. British Journal of Pharmacology [online], 2010, vol. 159, p. 1126-1132.
  • BUISSA FILHO, R., et al. The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected Balb/c mice challenged intratracheally with the fungus [doi:10.1128/IAI.00349-08]. Infection and Immunity [online], 2008, vol. 76, p. 3321-3328.
  • MARQUES, A. F., et al. Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis [doi:10.1016/j.micinf.2008.07.027]. Microbes and Infection [online], 2008, vol. 10, p. 1251-1258.
  • MARQUES, Alexandre Ferreira, et al. Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis [doi:10.1128/AAC.00220-06]. Antimicrobial Agents and Chemotherapy [online], 2006, vol. 50, nº 8, p. 2814-2819.
  • Reche, A., et al. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus [doi:10.1016/j.jfms.2009.12.017]. Journal of Feline Medicine and Surgery [online], 2010, vol. 12, p. 355-358.
  • RITTNER, Glauce Mary Gomes, et al. Therapeutic DNA Vaccine encoding peptide P10 against experimental paracoccidioidomycosis [doi:10.1371/journal.pntd.0001519]. Plos Neglected Tropical Diseases [online], 2012, vol. 6, p. 1-9.
  • SILVA, M. B., et al. Melanin in the Dimorphic Fungal Pathogen Paracoccidioides brasiliensis: Effects on Phagocytosis, Intracellular Resistance and Drug Susceptibility [doi:10.1016/j.micinf.2005.06.018]. Microbes and Infection [online], 2006, vol. 8, p. 197-205.
  • SILVA, M. B., et al. Resistance of melanized yeast cells of P. brasiliensis to antimicrobial oxidants and inhibition of phagocytosis using carbohydrates and monoclonal antibody to CD18 [doi:10.1590/S0074-02762009000400019]. Memórias do Instituto Oswaldo Cruz [online], 2009, vol. 104, p. 644-648.
  • TAVARES, P. M., et al. In Vitro Activity of the Antifungal Plant Defensin RsAFP2 against Candida Isolates and Its In Vivo Efficacy in Prophylactic Murine Models of Candidiasis [doi:10.1128/AAC.00448-08]. Antimicrobial Agents and Chemotherapy [online], 2008, vol. 52, p. 4522-4525.
  • Thomaz, L., et al. Experimental paracoccidioidomycosis: alternative therapy with ajoene, compound from Allium sativum , associated with sulfamethoxazole/trimethoprim [doi:10.1080/13693780701651681]. Medical Mycology (Oxford. Print) [online], 2008, vol. 46, p. 113-118.
  • AMARAL, A. C., et al. PLGA-P10 conjugate improved 20-times the immunological protection of this peptide agaisnt Paracoccidioides brasiliensis. In X International Congress on Paracoccidioidomycosis, Medellín, Colômbia, 2008. Biomédica., 2008. Abstract.
  • BUISSA FILHO, R., et al. Effect of monoclonal antibody against the major diagnostic antigen of P. brasilienis on the reduction of lung infection. In IX International Meeting on Paracoccidioidomycosis, Águas de Lindóia, 2005. Revista do Instituto de Medicina Tropical., 2005. Resumo.
  • BUISSA FILHO, R., et al. Utilização de anticorpos monoclonais contra o principal antigeno de diagnóstico do P. brasiliensis. In IV congresso do Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo, 2005. IV congresso do Instituto de Ciências Biomédicas da Universidade de São Paulo., 2005. Resumo.
  • Marques, A. F., et al. Atividade adjuvante do peptídeo sintético de camundongos BALB/c anérgicos e infectados intratraquealmente com Paracoccidioides brasiliensis. In 24 Congresso Brasileiro de Microbiologia, Brasilia, 2007. 24 Congresso Brasileiro de Microbiologia., 2007. Resumo.
  • MARQUES, Alexandre Ferreira, et al. Efeito sinérgico entre drogas antifúngicas e a imunização com o P10 no controle da paracoccidioidomicose experimental. In IV congresso do Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo, 2005. IV congresso do Instituto de Ciências Biomédicas da Universidade de São Paulo., 2005. Resumo.
  • MARQUES, Alexandre Ferreira, et al. Synergic effect of P10 immunization and chemotherapy in mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis. In 104 general meeting - American Society for Microbiology, New Orleans, 2004. 104 general meeting - American Society for Microbiology., 2004. Abstract.
  • MARQUES, Alexandre Ferreira, et al. Synergic effect of P10 immunization and chemotherapy in mice with established pulmonary paracoccidioidomycosis. In IX International Meeting on Paracoccidioidomycosis, Águas de Lindóia, 2005. Revista do Instituto de Medicina Tropical de São Paulo., 2005. Resumo.
  • MARQUES, Alexandre Ferreira, et al. Utilização de peptídeo sintético (P10) associado ao tratamento com drogas no controle da paracoccidioidomicose experimental. In IV Congresso Brasileiro de Micologia, Ouro Preto, 2004. IV Congresso Brasileiro de Micologia., 2004. Resumo.
  • Muñoz, J. E., et al. Immunização de camundongos BALB/c com peptídeo sintético (P10) associado à transferência passiva de anticorpos monoclonais contra a gp43 na paracoccidioidomicose experimental. In 24 Congresso Brasileiro de Microbiologia, Brasilia, 2007. 24 Congresso Brasileiro de Microbiologia., 2007. Resumo.
  • PINTO, M. R., et al. Glucosylceramide synthase: a possible regulator of pathogenicity of Candida albicans. In XXXVI Reunião Anual da SBBq, Salvador, 2007. XXXVI Reunião Anual da SBBq., 2007. Resumo.
  • Reche, A., et al. Cutaneous Mycoflora and CD4+:CD8+ Ratio of Cats Infected with Feline Immunodeficiency Virus. In 2009 ACVIM Forum/Canadian VMA Convention, montreal, 2009. ACVIM Forum., 2009. Abstract.
  • RITTNER, Glauce Mary Gomes, et al. Protective immunity against Paracoccidioides brasiliensis by a recombinant DNA vaccine enconding peptide 10 (P10) derived from the major diagnostic antigen, gp43. In 107 General Meeting - American Society for Microbiology, Toronto, 2007. 107 General Meeting - American Society for Microbiology., 2007. Resumo.
  • RUSSO, V., et al. Pesquisa da expressão de melanina e atividade lacase em amsotras de Fusarium solani. In 24 Congresso Brasileiro de Microbiologia, Brasilia, 2007. 24 Congresso Brasileiro de Microbiologia., 2007. Resumo.
  • SILVA, Cássia Jacqueline da, et al. Bioactive lipids in paracoccidioidomycosis: induction of specific antibodies that increase yeast cell phagocytosis. In 107 General Meeting - American Society for Microbiology, Toronto, 2007. 107 General Meeting - American Society for Microbiology., 2007. Abstract.
  • SILVA, M B da, et al. Envolvimento da melanina do fungo dimórfico P. brasiliensis na fagocitose e morte intracelular. In IV congresso do Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo, 2005. IV congresso do Instituto de Ciências Biomédicas da Universidade de São Paulo., 2005. Resumo.
  • SILVA, M. B., et al. Involvement of melanin from dimorphic fungal pathogen Paracoccidioides brasiliensis in phagocytosis and susceptibility to antimicrobial oxidants. In IX International Meeting on Paracoccidioidomycosis, Águas de Lindóia, 2005. Revista do Instituto de Medicina Tropical de São Paulo., 2005. Resumo.
  • TABORDA, C. P., MARQUES, Alexandre Ferreira, and TRAVASSOS, Luiz R. Combined P10 immunization and chemotherapy in mice challenged intratracheally with Paracoccidioides brasiliensis. In IX International Meeting on Paracoccidioidomycosis, Águas de Lindóia, 2005. Revista do Instituto de Medicina Tropical., 2005. Abstract.
  • Thomaz, L., et al. Utilização do ajoene no controle da paracoccidioidomicose experimental. In 24 Congresso Brasileiro de Microbiologia, Brasilia, 2007. 24 Congresso Brasileiro de Microbiologia., 2007. Resumo.
All rights of the thesis/dissertation are from the authors
CeTI-SC/STI
Digital Library of Theses and Dissertations of USP. Copyright © 2001-2024. All rights reserved.